echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yisheng Pharmaceutical's ginseng and Shengmai injections are listed in the recommended prescriptions and Chinese patent medicines for critically ill patients

    Yisheng Pharmaceutical's ginseng and Shengmai injections are listed in the recommended prescriptions and Chinese patent medicines for critically ill patients

    • Last Update: 2022-05-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 17, 2022, Yisheng Pharmaceutical announced that the company's products ginseng and Shengmai injection were included in the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" recommended prescription for critical patients during the clinical treatment period (confirmed cases).


    Ginseng has the functions of invigorating vitality, strengthening the pulse, nourishing the spleen and benefiting the lung, promoting body fluid and nourishing blood, soothing the nerves and nourishing the mind


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.